These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 22768080)

  • 1. Metadherin contributes to the pathogenesis of diffuse large B-cell lymphoma.
    Ge X; Lv X; Feng L; Liu X; Gao J; Chen N; Wang X
    PLoS One; 2012; 7(6):e39449. PubMed ID: 22768080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression and nuclear localization of β-catenin in diffuse large B-cell lymphoma.
    Ge X; Lv X; Feng L; Liu X; Wang X
    Mol Med Rep; 2012 Jun; 5(6):1433-7. PubMed ID: 22427053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Preliminary Study on Metadherin as a Potential Marker for Progression of Diffuse Large B Cell Lymphoma.
    Ge X; Sui X; Fang X; Jiang Y; Ding M; Liu X; Wang X
    Genet Test Mol Biomarkers; 2018 Aug; 22(8):481-486. PubMed ID: 30117777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXM1-induced upregulation of lncRNA OR3A4 promotes the progression of diffuse large B-cell lymphoma via Wnt/β-catenin signaling pathway.
    Meng H; Zhao B; Wang Y
    Exp Mol Pathol; 2020 Aug; 115():104451. PubMed ID: 32417392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing Aurora-kinase-A (AURKA) reinforced the sensitivity of diffuse large B-cell lymphoma cells to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) via suppressing β-Catenin and RAS-extracellular signal-regulated protein kinase (ERK1/2) pathway.
    Wang S; Sun L
    Bioengineered; 2021 Dec; 12(1):8296-8308. PubMed ID: 34565287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA FIRRE is activated by MYC and promotes the development of diffuse large B-cell lymphoma via Wnt/β-catenin signaling pathway.
    Shi X; Cui Z; Liu X; Wu S; Wu Y; Fang F; Zhao H
    Biochem Biophys Res Commun; 2019 Mar; 510(4):594-600. PubMed ID: 30739786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GPNMB promotes the progression of diffuse large B cell lymphoma via YAP1-mediated activation of the Wnt/β-catenin signaling pathway.
    Wang Z; Ran X; Qian S; Hou H; Dong M; Wu S; Ding M; Zhang Y; Zhang X; Zhang M; Chen Q
    Arch Biochem Biophys; 2021 Oct; 710():108998. PubMed ID: 34280359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TIMD4 exhibits regulatory capability on the proliferation and apoptosis of diffuse large B-cell lymphoma cells via the Wnt/β-catenin pathway.
    Li Y; Zhang PY; Yang ZW; Ma F; Li FX
    J Gene Med; 2020 Aug; 22(8):e3186. PubMed ID: 32187802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metadherin contributes to the pathogenesis of chronic lymphocytic leukemia partially through Wnt/β-catenin pathway.
    Li PP; Feng LL; Chen N; Ge XL; Lv X; Lu K; Ding M; Yuan D; Wang X
    Med Oncol; 2015 Feb; 32(2):479. PubMed ID: 25575438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL9 promotes the progression of diffuse large B-cell lymphoma through up-regulating β-catenin.
    Ruiduo C; Ying D; Qiwei W
    Biomed Pharmacother; 2018 Nov; 107():689-695. PubMed ID: 30130730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-MYC-activated lncRNA SNHG20 accelerates the proliferation of diffuse large B cell lymphoma via USP14-mediated deubiquitination of β-catenin.
    Wang C; Fu W; Zhang Y; Hu X; Xu Q; Tong X
    Biol Direct; 2024 Jun; 19(1):47. PubMed ID: 38886753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lnc SMAD5-AS1 as ceRNA inhibit proliferation of diffuse large B cell lymphoma via Wnt/β-catenin pathway by sponging miR-135b-5p to elevate expression of APC.
    Zhao CC; Jiao Y; Zhang YY; Ning J; Zhang YR; Xu J; Wei W; Kang-Sheng G
    Cell Death Dis; 2019 Mar; 10(4):252. PubMed ID: 30874550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metadherin interference inhibits proliferation and enhances chemo-sensitivity to doxorubicin in diffuse large B cell lymphoma.
    Li PP; Feng LL; Chen N; Lu K; Meng XH; Ge XL; Lv X; Wang X
    Int J Clin Exp Med; 2014; 7(8):2081-6. PubMed ID: 25232390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CircEAF2 counteracts Epstein-Barr virus-positive diffuse large B-cell lymphoma progression via miR-BART19-3p/APC/β-catenin axis.
    Zhao CX; Yan ZX; Wen JJ; Fu D; Xu PP; Wang L; Cheng S; Hu JD; Zhao WL
    Mol Cancer; 2021 Dec; 20(1):153. PubMed ID: 34852843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metadherin-PRMT5 complex enhances the metastasis of hepatocellular carcinoma through the WNT-β-catenin signaling pathway.
    Zhu K; Peng Y; Hu J; Zhan H; Yang L; Gao Q; Jia H; Luo R; Dai Z; Tang Z; Fan J; Zhou J
    Carcinogenesis; 2020 Apr; 41(2):130-138. PubMed ID: 31498866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G protein nucleolar 3 promotes Non-Hodgkin lymphoma progression by activating the Wnt/β-catenin signaling pathway.
    Dai R; Wu M; Zhang Y; Zhu Z; Shi J
    Exp Cell Res; 2021 Dec; 409(2):112911. PubMed ID: 34762898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of metadherin inhibits cell proliferation and migration in colorectal cancer.
    Li JW; Huang CZ; Li JH; Yuan JH; Chen QH; Zhang WF; Xu ZS; Liu YP; Li Y; Zhan MX; Lu LG
    Oncol Rep; 2018 Oct; 40(4):2215-2223. PubMed ID: 30015962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
    Li WF; Dai H; Ou Q; Zuo GQ; Liu CA
    Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MTDH is an oncogene in multiple myeloma, which is suppressed by Bortezomib treatment.
    Gu C; Feng L; Peng H; Yang H; Feng Z; Yang Y
    Oncotarget; 2016 Jan; 7(4):4559-69. PubMed ID: 26683226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycoprotein PTGDS promotes tumorigenesis of diffuse large B-cell lymphoma by MYH9-mediated regulation of Wnt-β-catenin-STAT3 signaling.
    Hu S; Ren S; Cai Y; Liu J; Han Y; Zhao Y; Yang J; Zhou X; Wang X
    Cell Death Differ; 2022 Mar; 29(3):642-656. PubMed ID: 34743203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.